Marc Began - 20 Mar 2023 Form 3 Insider Report for Axogen, Inc. (AXGN)

Role: EVP & General Counsel
Signature: Marc Began
Issuer symbol: AXGN
Transactions as of: 20 Mar 2023
Transactions value $: $0
Form type: 3
Date filed: 30 Mar 2023, 16:39
Previous filing: 27 Dec 2022
Next filing: 23 Feb 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	AXGN	Restricted Stock Units							20 Mar 2023	Common Stock	45K	$0.00	Direct	F1
holding	AXGN	Employee Stock Option (right to purchase)							20 Mar 2023	Common Stock	90K	$8.16	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 1, 2027 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 1, 2025 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date.

Content

All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 1, 2027 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 1, 2025 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date.